Radiofrequency ablation of colorectal liver metastases: Where are we really going?

Journal of Clinical Oncology

Volumn 23, Issue 7, 2005, Pages 1342-1344

  Poston, Graeme J ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CRYOSURGERY; EDITORIAL; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; CATHETER ABLATION; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; NOTE; PATHOLOGY;

CATHETER ABLATION; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 14944347662     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.10.911     Document Type: Editorial

References (56)

1. Curley SA, Izzo F, Delrio P, et al: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg 230:1-8, 1999
2. Jiao LR, Williamson RCN, Habib NA: Radiofrequency comes of age in liver surgery: Ablative technique and adjunct to resection. HPB 5:3-5, 2003
3. Gillams AR: Radiofrequency ablation in the management of liver tumours. Eur J Surg Oncol 29:9-16, 2003
4. Erce C, Parks RW: Interstitial ablative techniques for hepatic tumours. Br J Surg 90:272-289, 2003
5. Giovannini M, Moutardier V, Danisi C, et al: Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermablation: Results and outcomes in 56 patients. J Gastrointest Surg 7:791-796, 2003
6. Lam C-M, Ng KK-C, Poon RT-P, et al: Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre. Br J Surg 91:334-338, 2004
7. King J, Glenn D, Clark W, et al: Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 91:217-223, 2004
8. Morris D, Glenn D, Ling J, et al: Radiofrequency ablation (RFA) of pulmonary colorectal metastases. Proc Am Soc Clin Oncol 23:302, 2004 (abstr 3732)
9. Scudamore CH, Lee SI, Patterson EJ, et al: Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 177:411-417, 1999
10. Oshowo A, Gillams AR, Lees WR, et al: Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol 29:244-247, 2003
11. Tepel J, Hinz S, Klomp H-J, et al: Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies. Eur J Surg Oncol 30:551-555, 2004
12. Oshowo A, Gillams A, Harrison E, et al: Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90:1240-1243, 2003
13. Wiersinga WJ, Jansen MC, Straasburg IH, et al: Lesion progression with time and the effects of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 90:306-312, 2003
14. Mulier S, Ni Y, Miao Y, et al: Size and geometry of hepatic radiofrequency lesions. Eur J Surg Oncol 29:867-878, 2003
15. Berber E, Pelley R, Siperstein A: Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: A prospective study. J Clin Oncol 23:1358-1364, 2005
16. Alberts S, Poston GJ: OncoSurge: A strategy for long-term survival in metastatic colorectal cancer. Colorectal Dis 5:20-28, 2003 (suppl 3)
17. Allen PJ, Kemeny N, Jarnagin W, et al: Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7:109-117, 2003
18. Tanaka K, Adam R, Shimada H, et al: Role of neoadjuvant chemotherapy in the treatment of multiple colorectal liver metastases. Br J Surg 90:963-969, 2003
19. Eckburg H, Tranberg KG, Andersson R, et al: Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727-731, 1986
20. Hughes KS, Simon R, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 100:278-284, 1986
21. Nordlinger B, Quilichini M, Parc R, et al: Hepatic resection for colorectal liver metastases: Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 205:256-263, 1987
22. Bozzetti F, Doci R, Bignami P, et al: Patterns of failure following surgical resection of colorectal cancer liver metastases: Rationale for a multimodal approach. Ann Surg 205:264-270, 1987
23. Doci R, Gennari L, Bignami P, et al: One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 78:797-801, 1991
24. Scheele J, Stangl R, Altendorf-Hofmann A, et al: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13-29, 1991
25. Fong Y, Fortner J, Sun R, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-319, 1999
26. Topal B, Kaufman L, Aerts R, et al: Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol 29:248-253, 2003
27. Ueno H, Mochizuki H, Hasiguchi Y, et al: Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 91:327-333, 2004
28. Ravikumar TS, Kane R, Cady B, et al: A 5 year study of cryosurgery in the treatment of liver tumors. Arch Surg 126:1520-1524, 1991
29. Preketes AP, King J, Capelhorn JRM, et al: CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Aust N Z J Surg 64:612-614, 1994
30. Seifert JK, Morris DL: Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 228:201-208, 1998
31. Ruers TJM, Joosten J, Jager GJ, et al: Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 88:844-849, 2001
32. Sheen AJ, Poston GJ, Sherlock DJ: Cryotherapeutic ablation of liver tumours. Br J Surg 89:1396-1401, 2002
33. Stearns MW, Brinkley GJ: Palliative surgery for cancer of the colon and rectum. Cancer 7:1016-1019, 1954
34. Jaffe BM, Donegan WL, Watson F, et al: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127:1-11, 1968
35. Cady B, Monson DO, Swinton NW: Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131:697-700, 1970
36. Stangl R, Altendorf-Hofmann A, Charnley RM, et al: Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-1410, 1994
37. Rougier P, Milan C, Lazorthes F, et al: Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Br J Surg 82:1397-1400, 1995
38. Gillams A, Lees WR: Image guided ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 43:656-661, 2000
39. Siperstein A, Rogers SJ, Machi J, et al: Longterm follow-up of patients undergoing radiofrequency thermal ablation for primary and metastatic liver tumors: A multicenter trial. Presented at Am Coll Surg Clin Congress, San Francisco, CA, October 6-10, 2002 (abstr)
40. Tellez C, Benson A, Lyster MT, et al: Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82:1250-1259, 1998
41. Leichman CG, Jacobson JR, Modiano M, et al: Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial. Cancer 86:775-781, 1999
42. Kerr DJ, McArdle CS, Ledermann J, et al: Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial. Lancet 361:368-373, 2003
43. Elaraj DM, Alexander HR: Current role of hepatic artery infusion and isolated liver perfusion for the treatment of colorectal cancer liver metastases. Cancer 10:128-138, 2004
44. Goldberg RM, Sargent DJ, Morton RF, et al: A randomised controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30, 2004
45. Tournigand C, Andre T, Achille E, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomised GERCOR study. J Clin Oncol 22:229-237, 2004
46. Goldberg RM, Sargent DJ, Morton RF, et al: N9741: FOLFOX (oxaliplatin [oxal]/5-fluorouracil [5-FU]/leucovorin or reduced dose R-IFL [CPT-11+5FU/LV]) in advanced colorectal cancer (CRC): Final efficacy data from an Intergroup study. Proc Am Soc Clin Oncol 23:275, 2004 (abstr 3621)
47. Bismuth H, Adam R, Levi F, et al: Resection of non-resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509-522, 1996
48. Giacchetti S, Itzhaki M, Gruia G, et al: Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663-669, 1999
49. Adam R, Avisar E, Ariche A, et al: Five year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal (liver) metastases. Ann Surg Oncol 8:347-353, 2001
50. Alberts SR, Donohue JH, Mahoney MR, et al: Liver resection after 5-fluorouracil, leucovorin and oxaliplatin for patients with metastatic colorectal cancer (MCRC) limited to the liver: A North Central Cancer Treatment Group (NCCTG) phase II study. Proc Am Soc Clin Oncol 22:268, 2003 (abstr 1053)
51. Weymyss-Holden SA, Dennison AR, Finch GJ, et al: Electrolytic ablation as an adjunct to liver resection: Experimental studies of predictability and safety. Br J Surg 89:579-585, 2002
52. Teague BD, Court FG, Morrison CP, et al: Electrolytic liver ablation is not associated with evidence of a systemic inflammatory response syndrome. Br J Surg 91:178-183, 2004
53. Strickland AD, Clegg PJ, Cronin NJ, et al: Experimental study of large-volume microwave ablation in the liver. Br J Surg 89:1003-1007, 2002
54. Iannitti DA, Aswad B, Dupuy D: Hepatic microwave ablation using a clustered probe system: Results of a phase I ablate and resect clinical trial. HPB 6:16, 2004 (suppl 1)
55. Lloyd DM, Strickland AD, Clegg PJ, et al: Rapid large volume microwave tissue ablation (MTA) of unresectable liver tumours using a novel applicator. HPB 6:17, 2004 (suppl 1)
56. Gillams A, Lees WR: Image guided ablation of colorectal liver metastases: Time for a randomised controlled trial versus hepatic resection. Radiology 213:212, 1999 (abstr)